脑部放疗，上午比下午敏感许多！% H, f- N% X1 g! I3 M3 G0 ?! Y
2 _! a; i8 M! v: X+ y$ X2 |: o4 u
! D; K* }0 C! R2 [' _Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.% W1 N4 q3 x/ F7 C, y, j. W# E
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
- }! i/ D7 G+ e/ r! Q2 rRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
+ ?6 R" I8 b3 t) V: n1 a% FSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.# A* v* M% T+ d6 J. X' a- z
# q; s7 W @3 e) I5 S2 z
Abstract
3 W" g/ {% t" L0 F% f" iBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
. C9 `2 l/ I0 l$ w; E- @0 m* e6 C6 P1 G% @0 L& i' F5 T
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
9 [" {( o. y* O3 N, |/ y3 D) u# h6 Q6 w' `* g3 z
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
( Q9 N- j1 ?) r3 @9 y$ E* X) H) p% ~& `5 I5 H% D) `% x; S) `. X- W
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.% m$ B( ]6 M# u6 c1 E6 L
$ F( W+ Q3 f5 P# V" p |
$ g' V; L& w. d# e4 q6 J
显身卡
